Neil Roth, MD
Sports Medicine · New York, NYNPI 1689606998
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,944 of the $8,591 with a category attached, or 80.8%. Restor3d, Inc. accounts for 81.0% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $4,983 and has fallen 82.6% since, to $866 in 2025.
Across 42 payments — averaging $204.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Restor3d, Inc.$7K
- Lazurite Inc.$515
- Johnson & Johnson$492
- Ferring Pharmaceuticals Inc.$287
- Smith+Nephew$116
- Dynasplint Systems Inc.$89
- plus $133 from 5 others
Across 4 payments — averaging $98,481 each. An ownership or investment interest held by the physician or an immediate family member.
- Lazurite Inc.$394K
What the payments were for
- Consulting fees$6,94481%
- Food & beverage$1,64719%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Restor3d, Inc. | 8 | $6,959 |
| Lazurite Inc. | 1 | $515 |
| Johnson & Johnson | 10 | $492 |
| Ferring Pharmaceuticals Inc. | 13 | $287 |
| Smith+Nephew | 4 | $116 |
| Dynasplint Systems Inc. | 1 | $89 |
| Stryker | 1 | $38 |
| Bioventus LLC | 1 | $32 |
| Electronic Waveform Lab, Inc. | 1 | $28 |
| Fidia Pharma USA Inc. | 1 | $20 |
| Boston Scientific | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DYNACORD$125
- MILAGRO$125
- ATTUNE$125
- BRISTOW-LATARJET$100
How this compares
$8,591 in reported general payments places this provider in the 70th percentile of 403 sports medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 43 | $212 |
| Methylprednisolone | 14 | $71 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in New York
- Gregory DifeliceNew York$1.8M
- Theodore BlaineNew York$765K
- Robert MeislinNew York$720K
- Danyal NawabiNew York$592K
- Riley WilliamsNew York$512K
- Bryan KellyNew York$409K
- Samuel TaylorNew York$255K
- Eric StraussNew York$241K
- Michael FuNew York$210K
- Michael AlaiaNew York$207K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.